Tissue factor pathway inhibitor-2 is a novel inhibitor of matrix metalloproteinases with implications for atherosclerosis

Degradation of ECM, particularly interstitial collagen, promotes plaque instability, rendering atheroma prone to rupture. Previous studies implicated matrix metalloproteinases (MMPs) in these processes, suggesting that dysregulated MMP activity, probably due to imbalance with endogenous inhibitors,...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Herman, Michael P., Sukhova, Galina K., Kisiel, Walter, Foster, Don, Kehry, Marilyn R., Libby, Peter, Schönbeck, Uwe
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society for Clinical Investigation 2001
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC209273/
https://ncbi.nlm.nih.gov/pubmed/11342575
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky